CytoSorbents Corp (CTSO) - Market Cap to Earnings

Corporate emblem and logo of CytoSorbents Corporation (CTSO)

Cytosorbents (CTSO) leads the development of blood filtration systems for severe pathologies, supplying solutions to intensive care units. The company's technological base is integrated into hospital equipment to combat systemic inflammation. Despite a narrow specialization in a single field, the business is scaling globally. This price chart on the GURU.Markets platform shows that this multiple is -1.00.

CytoSorbents Corp (CTSO): Price to Earnings Ratio from 07/04/2022 to 11/10/2026

Comprehensive metric breakdowns and analytics for CytoSorbents Corp (CTSO)

- stock price and consensus target price:
Quote Chart CytoSorbents Corp.|CTSO - Analyst Consensus Forecast
- market capitalization indicators:
Market Value CytoSorbents Corporation|CTSO - Real Price to Acquire Entire Company
- book value of equity indicators:
Book Value per Share Cytosorbents|CTSO - Company Net Assets|Market Cap to Book Value Multiple cytosorbents.com|CTSO - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Cytosorbents|CTSO - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio CytoSorbents Corp.|CTSO - Company Total Debt|Debt to Net Assets Ratio CytoSorbents Corporation|CTSO - Company Long-Term Debt|Company Current Liabilities Cytosorbents|Immediate Liquidity cytosorbents.com
- net income and valuation ratios data:
CTSO - Net Profit|Net Profit Forecast Cytosorbents|CTSO - P/E Multiple|Market Cap to Projected Earnings CytoSorbents Corp.|CTSO - PEG Multiple|Enterprise Value to EBITDA Ratio CytoSorbents Corporation|CTSO - Operating profit EBITDA|Net earnings per share (EPS TTM) Cytosorbents|CTSO - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months cytosorbents.com|CTSO - Net earnings per share growth this year|Expected earnings per share trend next year Cytosorbents
General company analysis:cytosorbents.com - CTSO
Manufactured product of Cytosorbents

The P/E ratio measures the market value of a single unit of net profit, allowing an investor to determine the extent of overpayment for an asset or the risk of business undervaluation in real time. The current price-to-earnings ratio of -1.00 reflects market expectations regarding the monetization of Cytosorbents unique patents in the extracorporeal blood purification niche and the steady demand for proprietary consumables.

Analysis of competing companies

dexcom.com - Market Cap to Net Income|P/E Multiple PEN|NOVT - Market Cap to Earnings|Haemonetics Corp. - Price to Earnings Ratio|P/E Multiple Inspire Medical Systems Inc INSP|PRCT: Price to Earnings Ratio|conmed.com - Market Price to Net Income Ratio|PLSE: P/E Multiple|INMD - Business Payback Period|PMI (Picard Medical Inc.) - P/E Multiple|Price to Earnings Ratio Surmodics Inc. (SRDX)|Price to Earnings Ratio SENS (Senseonics)|NPCE (neuropace.com) - Company Value to Net Income|Price to Earnings Ratio Tactile Medical TCMD|SNWV - Price to Earnings Ratio|Outset - P/E Multiple|Market Cap to Earnings Electromed, Inc.|LNSR: P/E Multiple|Price to Earnings Multiple RCEL|PROF (Profound Medical Corp) - P/E Multiple|Baird Medical Corp (BDMD) - Business Payback Period|P/E Multiple EDAP|Price to Earnings Ratio apyxmedical.com APYX|P/E Multiple ICCM (IceCure Medical)|P/E Multiple Pulmonx Corp LUNG|TELA - Price to Earnings Ratio|SRTS: Price to Earnings Ratio|ZYXI (Zynex Inc) - Price to Earnings Ratio|electroCore - Company Value to Net Income|RBOT (Vicarious Surgical Inc) - P/E Multiple|Market Cap to Earnings Inspira Technologies Oxy B.H.N. Ltd IINN|Price to Earnings Ratio SeaStar Medical (ICU)|iridex.com (IRIX) - Market Cap to Net Income Ratio|Intelligent Bio Solutions Inc. - Price to Earnings Ratio|P/E Multiple Beyond Air Inc XAIR|Profusa Inc - P/E Multiple|Business Payback Period STRATA Skin Sciences SSKN|GlucoTrack, Inc. (GCTK) - Price to Earnings Ratio|Market Cap to Net Income NAOV (nanovibronix.com)|Price to Earnings Ratio Venus Concept Corp|Price to Earnings Ratio Nuwellis Corp (NUWE)|P/E Multiple AEMD|ASXC - Market Cap to Earnings|Price to Earnings Ratio Avinger AVGR|BSGM: Price to Earnings Multiple|CUTR: Price to Earnings Ratio|Know Labs Corporation - Market Price to Net Income Ratio|NARI: P/E Multiple|Price to Earnings Ratio nevro.com|Price to Earnings Ratio RSLS|Market Cap to Earnings Silk Road Medical, Inc. SILK